GGrantIndex
← Leaderboards

Amal N. Trivedi

Brown University

Google Scholar ↗PubMed ↗ORCID ↗
$14,732,060
Attributed
$16,036,442
Total exposure
17
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.1M · FY2009–25
$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,923,520 · 11
AHRQ$3,399,329 · 2
VA$0 · 5

By mechanism

P01$19,740,093 · 6
R01$9,146,903 · 5
T32$2,467,601 · 1
RC1$968,252 · 1
I01$0 · 5

Top collaborators

Most similar at Brown University

Same institution · by research overlap

Others in their field

Top investigators on “Caring”

Research focus

CaringPoliciesMedicareInnovationProgramsCostPaymentServicesProviderAlzheimer&AposHealthcareMortalityPersonsCommunitiesIncentivesAcuteComplexMedicaidHealth PolicyEnrollmentDesignLow IncomeHomeHealth Services

Grant awards (64)

Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems.$2,613,337
P01 · FY2025 · AG · contact PI
Impact of Randomized Payment Incentives on Disparities in Home Dialysis and Kidney Transplantation$628,833
R01 · FY2025 · MD · contact PI
Effects of Contract Terminations for Medicare Advantage Enrollees with Alzheimer's Disease and Related Dementias$267,061
P01 · FY2025 · AG · contact PI
Administrative Core$264,665
P01 · FY2025 · AG · contact PI
Impact of Dual Enrollment in the VA and Medicare Advantage on Care and Outcomes for Veterans$0
I01 · FY2025 · VA
Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems.$2,878,793
P01 · FY2024 · AG · contact PI
Impact of Randomized Payment Incentives on Disparities in Home Dialysis and Kidney Transplantation$625,332
R01 · FY2024 · MD · contact PI
Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease$520,578
R01 · FY2024 · DK · contact PI
Administrative Core$371,165
P01 · FY2024 · AG · contact PI
Effects of Contract Terminations for Medicare Advantage Enrollees with Alzheimer's Disease and Related Dementias$344,948
P01 · FY2024 · AG · contact PI
National Research Service Award$318,459
T32 · FY2024 · HS · contact PI
Impact of COVID-era Disrupted Care on Disparities in Outcomes among Veterans with Kidney Failure$0
I01 · FY2024 · VA
Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems$1,943,006
P01 · FY2023 · AG
Impact of Randomized Payment Incentives on Disparities in Home Dialysis and Kidney Transplantation$660,522
R01 · FY2023 · MD · contact PI
Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease$542,270
R01 · FY2023 · DK · contact PI
National Research Service Award$345,560
T32 · FY2023 · HS · contact PI
The Impact of Medicare Advantage on ADRD Care and Outcomes$258,678
P01 · FY2023 · AG · contact PI
Medicaid Expansion, Coverage Loss, and Disparities in Kidney Health in the COVID-19 Era$229,622
R01 · FY2023 · DK · contact PI
Impact of COVID-era Disrupted Care on Disparities in Outcomes among Veterans with Kidney Failure$0
I01 · FY2023 · VA
Impact of COVID-era Disrupted Care on Disparities in Outcomes among Veterans with Kidney Failure$0
I01 · FY2023 · VA
Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems$1,912,791
P01 · FY2022 · AG
Impact of Randomized Payment Incentives on Disparities in Home Dialysis and Kidney Transplantation$694,077
R01 · FY2022 · MD · contact PI
Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease$636,869
R01 · FY2022 · DK · contact PI
Infection Control Measures in Dialysis Facilities after COVID-19: Disparities in Adoption and Impact on Hospitalization and Mortality$452,233
R01 · FY2022 · HS · contact PI
National Research Service Award$351,884
T32 · FY2022 · HS · contact PI
The Impact of Medicare Advantage on ADRD Care and Outcomes$248,240
P01 · FY2022 · AG · contact PI
Medicaid Expansion, Coverage Loss, and Disparities in Kidney Health in the COVID-19 Era$229,494
R01 · FY2022 · DK · contact PI
Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems$2,008,227
P01 · FY2021 · AG
Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease$669,461
R01 · FY2021 · DK · contact PI
Infection Control Measures in Dialysis Facilities after COVID-19: Disparities in Adoption and Impact on Hospitalization and Mortality$479,495
R01 · FY2021 · HS · contact PI
National Research Service Award$386,339
T32 · FY2021 · HS · contact PI
Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems$271,658
P01 · FY2021 · AG
Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems$270,873
P01 · FY2021 · AG
The Impact of Medicare Advantage on ADRD Care and Outcomes$252,197
P01 · FY2021 · AG · contact PI
Medicaid Expansion, Coverage Loss, and Disparities in Kidney Health in the COVID-19 Era$228,780
R01 · FY2021 · DK · contact PI
Impact of VA Disability and Health Benefits on Long-Term Diabetes Outcomes among Vietnam-Era Veterans$0
I01 · FY2021 · VA · contact PI
Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems$1,869,487
P01 · FY2020 · AG
National Research Service Award$383,877
T32 · FY2020 · HS · contact PI
Impact of Medicaid Expansion on Racial and Socioeconomic Disparities in ESRD$380,041
R01 · FY2020 · DK · contact PI
The Impact of Medicare Advantage on ADRD Care and Outcomes$231,731
P01 · FY2020 · AG · contact PI
Risk-Adjusting Hospital Outcomes for Veteran's Socioeconomic Status$0
I01 · FY2020 · VA · contact PI
Impact of VA Disability and Health Benefits on Long-Term Diabetes Outcomes among Vietnam-Era Veterans$0
I01 · FY2020 · VA · contact PI
Risk-Adjusting Hospital Outcomes for Veteran's Socioeconomic Status$0
I01 · FY2020 · VA · contact PI
Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems$2,518,235
P01 · FY2019 · AG
Impact of Medicaid Expansion on Racial and Socioeconomic Disparities in ESRD$389,253
R01 · FY2019 · DK · contact PI
National Research Service Award$353,240
T32 · FY2019 · HS · contact PI
The Impact of Medicare Advantage on ADRD Care and Outcomes$314,419
P01 · FY2019 · AG · contact PI
Impact of Medicaid Expansion on Racial and Socioeconomic Disparities in ESRD$402,104
R01 · FY2018 · DK · contact PI
National Research Service Award$328,242
T32 · FY2018 · HS · contact PI
EFFECTS OF COST-SHARING FOR POST ACUTE CARE: EVIDENCE FROM MEDICARE ADVANTAGE$197,303
P01 · FY2018 · AG · contact PI
Impact of VA Disability and Health Benefits on Long-Term Diabetes Outcomes among Vietnam-Era Veterans$0
I01 · FY2018 · VA · contact PI
Risk-Adjusting Hospital Outcomes for Veteran's Socioeconomic Status$0
I01 · FY2018 · VA · contact PI
Risk-Adjusting Hospital Outcomes for Veteran's Socioeconomic Status$0
I01 · FY2018 · VA · contact PI
Impact of Medicaid Expansion on Racial and Socioeconomic Disparities in ESRD$384,764
R01 · FY2017 · DK · contact PI
EFFECTS OF COST-SHARING FOR POST ACUTE CARE: EVIDENCE FROM MEDICARE ADVANTAGE$182,599
P01 · FY2017 · AG · contact PI
EFFECTS OF COST-SHARING FOR POST ACUTE CARE: EVIDENCE FROM MEDICARE ADVANTAGE$193,351
P01 · FY2016 · AG · contact PI
Cost-Sharing, Use, and Outcomes of Post-Acute Care in Medicare Advantage Plans$284,864
R01 · FY2015 · AG · contact PI
EFFECTS OF COST-SHARING FOR POST ACUTE CARE: EVIDENCE FROM MEDICARE ADVANTAGE$163,187
P01 · FY2015 · AG · contact PI
Cost-Sharing, Use, and Outcomes of Post-Acute Care in Medicare Advantage Plans$336,601
R01 · FY2014 · AG · contact PI
EFFECTS OF COST-SHARING FOR POST ACUTE CARE: EVIDENCE FROM MEDICARE ADVANTAGE$164,142
P01 · FY2014 · AG · contact PI
Cost-Sharing, Use, and Outcomes of Post-Acute Care in Medicare Advantage Plans$371,710
R01 · FY2013 · AG · contact PI
Health Policy Implication of Dual Enrollment in the VA and Medicare Advantage$0
I01 · FY2013 · VA · contact PI
Effect of Prescription Drug Benefits on Cardiovascular Outcomes in the Elderly$469,865
RC1 · FY2010 · AG · contact PI
Effect of Prescription Drug Benefits on Cardiovascular Outcomes in the Elderly$498,387
RC1 · FY2009 · AG · contact PI